Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo Study
Basic & Clinical Pharmacology & Toxicology · 2026
DOI: 10.1111/bcpt.70199 ↗At a glance
Journal article in Basic & Clinical Pharmacology & Toxicology, 2026. Written by Aya Y Al-Kabariti and 3 co-authors. Institution: Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan. Major MEDLINE topics: TRPV Cation Channels, Diosmin, Acetylcholinesterase, Analgesics. Cited 2 times so far (Crossref); 44 references.
Abstract (original language)
Background
Diosmin, a flavonoid glycoside with reported anti‐inflammatory effects, was evaluated for its potential analgesic activity using in vivo and in silico studies.
Methods
The antinociceptive effect of diosmin was evaluated in mice using capsaicin‐ and formalin‐induced paw‐licking tests as well as hot plate and tail flick assays. Target prediction using Similarity Ensemble Approach (SEA) and molecular docking were conducted to validate diosmin's interaction with Transient Receptor Potential Vanilloid 1 (TRPV1) and acetylcholinesterase (AChE) in silico.
Findings
Diosmin (60 and 30 mg/kg) significantly reduced pain behaviour by 90.8% and 83.2%, respectively, in the capsaicin‐induced paw‐licking test, while BCTC, a TRPV1 antagonist, significantly blocked diosmin action. In the formalin test, atropine significantly blocked the action of diosmin at the early phase. Diosmin at 60 mg/kg increased hot plate latency by 104.8%. In the tail flick test, diosmin at 60 and 30 mg/kg increased latency by 103.7% and 90.6%, respectively, indicating central analgesic effects. No significant alterations in body temperature were observed. Docking studies confirmed diosmin's favourable binding to the active site of AChE with a binding energy of −9.77 kcal/mol. Diosmin engages the TRPV1 vanilloid pocket mainly through hydrophobic interactions.
Conclusion
Diosmin exerts central and peripheral antinociceptive effects mediated, at least partially, through TRPV1 antagonism and cholinergic pathways.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
- Pharmacological and Diagnostic Research Center, Al-Ahliyya Amman University, Amman, Jordan.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
- Department of Anatomy and Histology, School of Medicine, The University of Jordan, Amman, Jordan.
- Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman, Jordan.
ORCID profiles: Manal A Abbas
Cite
APA
Al-Kabariti, A. Y., Al-Najjar, B. O., Alsalem, M., & Abbas, M. A. (2026). Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo Study. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70199
Vancouver
Al-Kabariti AY, Al-Najjar BO, Alsalem M, Abbas MA. Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo Study. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70199
BibTeX
@article{AlKabariti2026,
author = {Al-Kabariti, Aya Y and Al-Najjar, Belal O and Alsalem, Mohammad and Abbas, Manal A},
title = {Diosmin Alleviates Pain via Mechanisms Involving Acetylcholinesterase and TRPV1 Inhibition: An In Silico and In Vivo Study},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
doi = {10.1111/bcpt.70199}
}
EUVIMED